2 women sitting cross-legged across from one another smiling and laughing in front of a blue sky

Together We Can Transform Diagnostics

Partner with Atomo for an efficient, low-risk pathway from product development to commercialization of your best-in-class rapid diagnostic test. Today’s users are demanding more. They expect more choices in rapid tests that can reliably be done at home, giving them more control and keeping them more informed.

With the growing demand for rapid tests, Atomo is a launching pad for new opportunities and new market segments. For partners who are looking to diversify or improve their current offerings, Atomo offers knowledge and expertise in point of care and at-home diagnostics. By leveraging over a decade’s worth of user-centered design and research and development, we can develop tests that will reach new market segments and demonstrate superior performance well ahead of industry standards. Our platform and partnership pathway are flexible, allowing us to deliver solutions from designing bespoke devices through commercializing fully finished products
3D render of clipboard with indiscernible writing and the Atomo logo in the top left-hand corner

Co-Development

Work with us for bespoke solutions that leverage our existing technology, allow for cost-sharing of new developments, and create locked-in customer relationships through supply, distribution, licensing and royalties.

3D render of red paper plane with curved dotted line behind it

Technology Sharing

Atomo’s development and usability expertise, portfolio of patent protected technologies and proprietary know-how can enhance your portfolio of assets, product offerings and sample types.

We aim to change how testing is performed at home and in clinical settings. We are eager to partner with your team to expand access to better rapid tests through the commercialization of our technologies via a white label and / or supply agreement.

Three-Step Process for Co-Development

3D render of white magnifying glass with grey interior

Select Your RDT Platform

The AtomoRapid™ range includes patented RDT platforms with assorted features to meet requirements for professional use and self-test applications.

3D render of 2 gears in white, one large and one small

Customize Your Device

Platforms are customizable to suit your requirements and can be modified to match desired specifics.

3D render of column chart style graphic

Commercialization

From manufacturing process validation to post-launch marketing, benefit from Atomo's dedicated support at every stage.

Easy-to-Use Applications

We can develop bespoke cloud-based applications or integrate with your systems which will make home-testing, telemedicine, public health monitoring seamless and easy.

3D render of two phone screens showing a QR code with buttons and a generic Atomo homescreen

Atomo Buddy

Patient will be able to easily access and provide important COVID related information using Atomo Buddy.

3D render of two phone screens showing a woman smiling at a diagnostic test and a generic Atomo homescreen

Atomo Pro

Our unique app will help bring information from the patient to the doctor all in one place.

3D render of a desktop computer showing an Atomo logo

Atomo Portal

The information collected from the test is then accessible in the Atomo Web Portal. This allows for multiple patient results to be viewed for quicker access.

Testimonials

Side on teardrop logo with letters NG inside sitting above the words NG Biotech Laboratoires

“Atomo has created a product that addresses unmet user needs in POC testing with superior accuracy, usability and simplicity.”

-Milovan Stankov Puges
CEO

Diamond formation artwork with a dark blue to light blue gradient with the words Access Bio to the right

“Atomo’s all-in-one test devices, which simplify and standardize test procedures, will help us improve the performance and user-friendliness of our HIV test for our customers.”

-Young Ho Choi
CEO & Founder

Icon of 2 individuals in red inside a grey circle with an arrow to the left of the words Global Health Investment Fund

"These solutions reduce error rates and improve care and have significant commercial potential in both the developing world and in developed healthcare markets."

- Dr. Curt LaBelle
Managing Partner

Partner Stories